|Published||Report Code||Available Format||Pages|
U.S. BPH Procedures Overview
Benign Prostatic Hyperplasia (BPH) refers to an enlarged prostate gland. The prostate gland surrounds the urethra, the tube that carries urine from the bladder out of the body. As the prostate gets bigger, it may squeeze or partly block the urethra, causing problems while urinating. BPH is common in aging men, and about half of all men between the age of 51 and 60 suffer from BPH. It has been observed that up to 90% of men over the age 80 years suffer from BPH. The treatment methods for BPH include medications, transurethral resection of the prostate (TURP), transurethral incision of the prostate (TUIP), laser based treatment and other energy based treatments such as implants and prostatic artery embolization.
U.S. BPH PROCEDURES, BY TYPE (2013 – 2023)
Laser based, surgical, UroLift and other energy based procedures are involved in the treatment of BPH disorders. Among different type of BPH treatment procedures, UroLift is expected to witness the fastest growth during the forecast period owing to the aging U.S. population, expanding insurance coverage of the procedure by various insurers, and low cost of the procedure.
Laser based procedures held the largest share in 2016, since these procedures are more effective, as compared to the conventional procedures and are less likely to cause bleeding and other complications. Laser based BPH procedures are further bifurcated into green light lasers, holmium lasers, thulium lasers and others. Green light lasers registered the largest share of the total number of laser based BPH procedures performed in 2016, in the U.S., mainly due to their efficacy and advantages over other laser based procedures for the treatment of BPH. Green light laser procedure enables quick recovery with minimal short-term side effects and comfort of urinary flow of the patients.
Access Report on: Global BPH Procedures
U.S. BPH Procedures Dynamics
Growing aging population, rising prevalence of BPH disorders, technological advancements in BPH procedures and rising awareness about BPH disorders and the treatments available are some of the factors increasing the number of BPH treatment procedures in the U.S. However, the adoption of BPH procedures in the U.S has been facing certain challenges such as side-effects associated with BPH treatment procedures and unfavourable healthcare reforms in the U.S., which is likely to impede its growth during the forecast period. Moreover, increasing reimbursement coverage for BPH procedures offer ample opportunities to the players to develop advanced BPH treatment therapies.
U.S. BPH Procedures - Competitive Landscape
Key player in the U.S. BPH procedures are introducing new advanced products for BPH treatment and gaining public and private insurance coverage. For instance, in May 2017, NeoTract, Inc. announced that its patent UroLift system has received insurance coverage for the treatment of BPH from Cigna Insurance Services Co., a global health service company that provides insurance to over 14 million Americans.
Some of the other key players providing BPH procedures in the U.S. include NxThera, Inc., Boston Scientific Corporation, Urologix, LLC., Convergent Laser Technologies.
Scope for Customization
P&S Intelligence offers customization as per specific business requirements of clients. Illustrative customization within the scope of this report includes: